Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
July 31, 2003
Study Completion Date
February 28, 2005
Conditions
AnemiaLung Cancer
Interventions
BIOLOGICAL
methoxy polyethylene glycol epoetin beta
Trial Locations (1)
90095-1781
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00072059 - Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter